LAFQX
Price
$19.98
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Net Assets
6.22B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAFQX vs VVIAX

Header iconLAFQX vs VVIAX Comparison
Open Charts LAFQX vs VVIAXBanner chart's image
Lord Abbett Affiliated R2
Price$19.98
Change+$0.13 (+0.65%)
VolumeN/A
Net Assets6.22B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LAFQX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAFQX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFQX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LAFQX (6.22B). VVIAX pays higher dividends than LAFQX: VVIAX (2.18) vs LAFQX (1.12). LAFQX was incepted earlier than VVIAX: LAFQX (18 years) vs VVIAX (25 years). LAFQX (1.04) is less costly to investors than VVIAX (0.05). LAFQX is a more actively managed with annual turnover of: 44.00 vs. VVIAX (9.00). LAFQX has a lower initial minimum investment than VVIAX: LAFQX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. LAFQX (10.02). VVIAX return over 5 years is better than : 80.13 vs. LAFQX (60.12).
LAFQXVVIAXLAFQX / VVIAX
Total Expense Ratio1.040.052,080%
Annual Report Gross Expense Ratio1.040.052,080%
Fund Existence18 years25 years-
Gain YTD7.4336.198120%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B189B3%
Annual Yield % from dividends1.122.1851%
Returns for 1 year10.0212.0383%
Returns for 3 years31.4835.1790%
Returns for 5 years60.1280.1375%
Returns for 10 years38.58115.6733%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.